Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

DaVita HealthCare Partners Inc

Healthcare US DVA

210.93USD
1.25(0.60%)

Last update at 2026-06-23T20:01:00Z

Day Range

209.95213.82
LowHigh

52 Week Range

101.00159.42
LowHigh

Fundamentals

  • Previous Close 209.68
  • Market Cap10020.66M
  • Volume650801
  • P/E Ratio15.78
  • Dividend Yield-%
  • EBITDA2751.16M
  • Revenue TTM13643.07M
  • Revenue Per Share TTM183.80
  • Gross Profit TTM 4400.59M
  • Diluted EPS TTM9.50

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1346.82M 1530.39M 1177.09M 966.28M 1518.49M
Minority interest -331.91300M -314.39500M -265.44300M 221.24M 233.31M
Net income 746.80M 936.34M 691.53M 768.19M 978.45M
Selling general administrative 1673.63M 1538.34M 1473.98M 1355.20M 1195.34M
Selling and marketing expenses - - - - -
Gross profit 3684.24M 4217.03M 3820.43M 3400.34M 3646.38M
Reconciled depreciation 715.35M 723.86M 745.44M 732.60M 680.62M
Ebit 1926.75M 2000.86M 1575.64M 1339.06M 1797.37M
Ebitda 2642.10M 2724.72M 2321.09M 2055.90M 2484.36M
Depreciation and amortization 715.35M 723.86M 745.44M 716.84M 686.99M
Non operating income net other - - - -15.76500M 6.38M
Operating income 2010.62M 2090.48M 1602.78M 1339.06M 1797.37M
Other operating expenses 11632.45M 10725.07M 10537.36M 10297.35M 9848.36M
Interest expense 549.67M 470.47M 398.55M 357.02M 285.25M
Tax provision 293.11M 279.66M 220.12M 198.09M 306.73M
Interest income 579.93M 470.47M 398.55M 357.02M 285.25M
Net interest income -579.92600M -470.46900M -398.55100M -357.01900M -285.25400M
Extraordinary items 25.00M 0.00000M 0.00000M 13.45M 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 293.11M 279.66M 220.12M 198.09M 306.73M
Total revenue 13643.07M 12815.55M 12140.15M 11609.89M 11618.80M
Total operating expenses 1673.63M 2126.55M 2217.65M 2087.80M 1875.95M
Cost of revenue 9958.82M 8598.52M 8319.72M 8209.55M 7972.41M
Total other income expense net -663.79200M -560.09000M -425.69000M -372.78400M -278.87600M
Discontinued operations - - - 13.45M 13.45M
Net income from continuing ops 1053.72M 1250.74M 956.98M 768.19M 1211.76M
Net income applicable to common shares 746.80M 936.34M 691.53M 560.40M 978.45M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 17480.10M 17285.27M 16893.58M 16928.25M 17121.49M
Intangible assets 222.12M 197.43M 203.22M 182.69M 177.69M
Earning assets - - - - -
Other current assets 156.28M 235.38M 187.22M 78.84M 165.58M
Total liab 16321.66M 15193.92M 14150.23M 14703.45M 14750.51M
Total stockholder equity 1158.44M 2091.35M 2743.35M 712.33M 755.51M
Deferred long term liab - - - 782.79M 830.95M
Other current liab 1910.80M 2415.91M 1581.48M 730.38M 709.35M
Common stock 0.07M 0.09M 0.09M 0.09M 0.10M
Capital stock 0.07M 0.09M 0.09M 0.09M 0.10M
Retained earnings -328.42800M 1534.63M 598.29M 174.49M 354.34M
Other liab - - - 888.02M 950.11M
Good will 7545.10M 7375.22M 7112.56M 7076.61M 7046.24M
Other assets 246.52M -115.02000M 725.90M 0.00100M 136.68M
Cash 757.75M 794.93M 380.06M 244.09M 461.90M
Cash and equivalents 676.44M 794.93M 380.06M 244.09M 461.90M
Total current liabilities 3141.63M 2973.41M 2642.21M 2619.75M 2398.53M
Current deferred revenue - - 28.51M 782.79M 713.75M
Net debt 14292.24M 10590.62M 10736.36M 11578.40M 11513.35M
Short term debt 534.68M 681.28M 517.70M 626.80M 573.39M
Short long term debt 109.20M 270.87M 123.30M 231.40M 179.03M
Short long term debt total 12874.33M 12066.84M 11116.42M 11822.49M 11975.25M
Other stockholder equity -199.94000M -1102.80200M 509.80M 606.93M 540.32M
Property plant equipment 5210.15M 5334.47M 5574.90M 3256.40M 3479.97M
Total current assets 4058.00M 3746.07M 3137.91M 3155.29M 3167.72M
Long term investments 198.22M 370.34M 593.74M 275.44M 288.39M
Net tangible assets - - - -5198.06300M -5033.59400M
Short term investments 24.30M 51.06M 11.61M 77.69M 22.31M
Net receivables 2959.04M 2530.14M 2415.91M 2550.65M 2410.51M
Long term debt 10163.99M 9175.90M 8268.33M 8692.62M 8729.15M
Inventory 160.63M 134.56M 143.10M 109.12M 107.43M
Accounts payable 696.15M 547.20M 514.53M 479.78M 402.05M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 163.57M 180.64M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -122.78300M -310.79600M -52.08400M -69.18600M -139.24700M
Additional paid in capital - - - - -
Common stock total equity - - - 0.09M 0.10M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 174.49M 354.34M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 246.52M 261.73M 271.25M -467.20000M -694.27700M
Deferred long term asset charges - - - - -
Non current assets total 13422.10M 13654.22M 13755.67M 13772.96M 13953.76M
Capital lease obligations 2601.14M 2209.66M 2330.39M 2898.47M 3067.07M
Long term debt total 12339.65M 11385.56M 10598.72M 8692.62M 8729.15M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 29.70M -771.42900M -816.76800M -83.60200M -14.69500M
Change to liabilities - - - 172.27M -110.49300M
Total cashflows from investing activities -654.94900M -771.42900M -771.80000M -630.34700M -784.73300M
Net borrowings 823.43M 1109.10M -552.61500M -11.27900M 754.25M
Total cash from financing activities -1374.78000M -816.93700M -1170.49500M -1121.12800M -1082.96600M
Change to operating activities - - - 85.87M -14.82000M
Net income 1078.72M 1250.74M 691.53M 781.64M 1211.76M
Change in cash -122.07800M 415.19M 125.64M -215.97100M 53.17M
Begin period cash flow 879.83M 464.63M 338.99M 554.96M 501.79M
End period cash flow 757.75M 879.83M 464.63M 338.99M 554.96M
Total cash from operating activities 1886.50M 2022.04M 2059.03M 1564.57M 1930.88M
Issuance of capital stock - 20.45M 16.90M - -
Depreciation 715.35M 723.86M 745.44M 732.60M 680.62M
Other cashflows from investing activities -36.34200M 32.54M 35.52M 56.68M -128.57300M
Dividends paid - - - 267.95M 244.03M
Change to inventory -19.95000M 17.94M -32.13200M -0.75700M 5.72M
Change to account receivables -210.63200M -29.76600M 172.36M -148.39400M -138.14000M
Sale purchase of stock -1792.99900M -1385.93200M -272.21900M -839.59500M -1598.62700M
Other cashflows from financing activities -374.68700M -560.55500M -362.56100M 2122.86M 1376.78M
Change to netincome - - - 50.22M 179.14M
Capital expenditures 575.86M 555.44M 567.99M 603.43M 641.47M
Change receivables - - - -120.86100M -9.47900M
Cash flows other operating - - - -50.54900M -26.38700M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - -186.90500M 63.18M
Change in working capital -263.24100M -29.82100M 194.53M 0.10M -140.63900M
Stock based compensation 139.95M 102.79M 112.38M 95.43M 102.21M
Other non cash items 129.15M 32.31M 354.50M 30.47M 16.45M
Free cash flow 1310.64M 1466.60M 1491.05M 961.14M 1289.41M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DVA
DaVita HealthCare Partners Inc		 1.25 0.60% 210.93 15.78 10.79 0.73 21.63 1.62 8.39
HCA
HCA Healthcare, Inc.		 9.93 2.63% 386.92 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.17 1.50% 11.47 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 -0.15 3.30% 4.40 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita HealthCare Partners Inc

2000 16th Street, Denver, CO, United States, 80202

Key Executives

Name Title Year Born
Mr. Javier J. Rodriguez CEO & Exec. Director 1971
Mr. Joel Ackerman CFO & Treasurer 1965
Ms. Kathleen Alyce Waters Chief Legal & Public Affairs Officer 1968
Mr. James O. Hearty Chief Compliance Officer 1969
Mr. Michael David Staffieri Chief Operating Officer of Kidney Care 1974
Mr. John D. Winstel Chief Accounting Officer 1971
Mr. Jim Gustafson VP of Investor Relations NA
Mr. Kenneth Gardner Smith Chief People Officer 1981
Mr. Atul Mathur Exec. VP of Global Operations NA
Dr. Abdulkareem Alsuwaida FRCPC, M.D., MSc Chief Medical Officer - Saudi Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions